Total synthesis of 12-methoxydihydrochelerythrine and anti-tumour activity of its quaternary base: Toward an efficient synthetic route for 12-alkoxybenzo[c]phenanthridine bases via naphthoquinone monooxime from 2-benzofuranyl-1-tetralone derivative

Organic and Biomolecular Chemistry

Volumn 1, Issue 17, 2003, Pages 3024-3032

  Watanabe, Toshiko ^a   Ohashi, Yoshiaki ^a   Yoshino, Rie ^a   Komano, Naoko ^a   Eguchi, Miyuki ^a   Maruyama, Sakiko ^b   Ishikawa, Tsutomu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINITY; AROMATIZATION; BIOCHEMISTRY; CELLS; DERIVATIVES; NITROGEN COMPOUNDS; REDUCTION; SYNTHESIS (CHEMICAL); THERMAL EFFECTS;

ALKOXYBENZOPHENANTHRIDINE; ANTI-TUMOUR ACTIVITY; BENZOFURANYLTETRALONE; CANCER CELLS; METHOXYDIHYDROCHELERYTHRINE; NAPTHAQUINONE MONOOXIME; QUARTERNARY BASE; SYNTHETIC ROUTE;

AROMATIC COMPOUNDS;

BOCCONIA; BOCCONIA INTEGRIFOLIA;

12 METHOXYDIHYDROCHELERYTHRINE; 12-METHOXYDIHYDROCHELERYTHRINE; 2 BENZOFURANYL 1 TETRALONE; 2-BENZOFURANYL-1-TETRALONE; ANTINEOPLASTIC AGENT; BENZOFURAN DERIVATIVE; BENZOPHENANTHRIDINE DERIVATIVE; NAPHTHOQUINONE; NAPHTHOQUINONE MONOOXIME; OXIME; PHENANTHRIDINE DERIVATIVE; TETRALIN DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG SCREENING; HUMAN; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BENZOFURANS; BENZOPHENANTHRIDINES; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; NAPHTHOQUINONES; OXIMES; PHENANTHRIDINES; TETRALONES;

EID: 0141518585     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/b304216m     Document Type: Article

References (29)

1. T. Ishikawa and H. Ishii, Heterocycles, 1999, 50, 627.
2. (a) W. M. Suffiness and G. A. Gordell, in The Alkaloids, ed. A. Brossi, Academic Press, New York, 1983, vol. 25, p. 178
3. (b) V. Simanek in The Alkaloids, ed. A. Brossi, Academic Press, New York, 1983, vol. 26, p. 185
4. (c) J. M. Herbert, J. M. Angereau,. J. Gleye and J. P. Maffrand, Biochem. Biophys. Res. Commun., 1990, 172, 993
5. (d) S.-D. Fang, L.-K. Wang and S. M. Hecht, J. Org. Chem., 1993, 58, 5025
6. (e) C. Vavreckova, I. Gawlik and K. Müller, Planta Med., 62, 397
7. (f) T. Schmeller, B. Laz-Bruning and M. Wink, Phytochemistry, 1997, 44, 257
8. (g) T. Nakanishi, M. Suzuki, A. Saimoto and T. Kawabata, J. Nat. Prod., 1998, 61, 1263
9. (h) T. Nakanishi, M. Suzuki, A. Saimoto and T. Kawabata, J. Nat. Prod., 1999, 62, 864
10. (i) F. Fleury, A. Sukhanova, A. Ianoul, J. Devy, I. Kudelina, O. Duval, A. J. P. Alix, J. C. Jardillier and I. Nabiev, J. Biol. Chem., 2000, 275, 3501.
11. (a) H. Ishii, Y.-I. Ichikawa, E. Kawanabe, M. Ishikawa, T. Ishikawa, M. Inomata and A. Hoshi, Chem. Pharm. Bull., 1985, 33, 4139
12. (b) H. Ishii, T. Ishikawa, S. Takeda, M. Suzuki and T. Harayama, Chem. Pharm. Bull., 1992, 40, 2002
13. T. Ishikawa, A. Takami, M. Abe, I.-S. Chen, T. Harayama and H. Ishii, Chem. Pharm. Bull., 1995, 43, 766.
14. T. Ishikawa, T. Saito and H. Ishii, Tetrahedron, 1995, 51, 8447.
15. M. A. Lynch, O. Duval, A. Sukhanova, J. Devy, S. P. MacKay, R. D. Waight and I. Nabiev, Bioorg. Med. Chem. Lett., 2001, 11, 2643.
16. S. M. Oechslin, G. M. König, K. Oechslin-Merkel, A. D. Wright, A. D. Kinghorn and O. Sticher, J. Nat. Prod., 1991, 54, 519.
17. T. Harayama, T. Akiyama, H. Akamatsu, K. Kawano, H. Abe and Y. Takeuchi, Synthesis, 2001, 444.
18. T. Ishikawa, K. Nagai, N. Ohkubo and H. Ishii, Heterocycles, 1994, 39, 371.
19. H. Ishii, I.-S. Chen, S. Ueki, T. Masuda, K. Morita and T. Ishikawa, J. Chem. Soc., Perkin Trans. 1, 1987, 2415.
20. H. Ishii, T. Ishikawa, S. Takeda, S. Ueki and M. Suzuki, Chem. Pharm. Bull., 1992, 40, 1148.
21. T. Ishikawa, T. Watanabe, H. Tanigawa, T. Saito, K.-I. Kotake, Y. Ohashi and H. Ishii, J. Org. Chem., 1996, 61, 2774.
22. 13 in pyridine
23. T. Isobe and T. Ishikawa, J. Org. Chem., 1999, 64, 6984.
24. H. Ishii, T. Ishikawa, Y.-I. Ichikawa, M. Sakamoto, M. Ishikawa and T. Takahashi, Chem. Pharm. Bull., 1984, 32, 2984.
25. 7 did not comment on this questinable point.
26. (a) T. Nakanishi, A. Masuda, M. Suwa, Y. Akiyama, N. Hoshino-Abe and M. Suzuki, Bioorg. Med. Chem. Lett., 2000, 10, 2321
27. (b) M. Fukuda, M. Inomata, K. Nishio, K. Fukuoka, F. Kanzawa, H. Arioka, T. Ishida, H. Fukumoto, H. Kurokawa, M. Oka and N. Saijo, Jpn. J. Cancer Res., 1996, 87, 1086.
28. Anhydrous palladium chloride (1.0 g) was dissolved in concentrated hydrochloric acid (2.5 mL) and water (6.0 mL). Then, the total volume of the resulting solution was made up to 60 mL by addition of water; H. Ishii, E. Kawanabe, K.-I. Harada, T. Deushi, E. Ueda, T. Watanabe, Y.-I. Ichikawa, M. Sakamoto, T. Ishida, T. Takahashi, K. Nakajima and T. Ishikawa, Chem. Pharm. Bull., 1983, 31, 3039.
29. No description of the melting point of 6 in ref 6.